Assembly Biosciences (NASDAQ:ASMB) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $(0.65) by 300 percent. This is a 182.8 percent increase over losses of $(1.57) per share from the same period last year. The company reported quarterly sales of $42.469 million which beat the analyst consensus estimate of $7.423 million by 472.15 percent. This is a 477.26 percent increase over sales of $7.357 million the same period last year.